EYPT Butterfly Strategy
EYPT (EyePoint Pharmaceuticals, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
EyePoint Pharmaceuticals, Inc. is a pharmaceutical firm dedicated to the creation and marketing of ophthalmic solutions for various eye ailments. Its operations span the United States, China, and the United Kingdom. Among its commercialized product portfolio are ILUVIEN, an injectable, sustained-release micro-insert designed to treat diabetic macular edema, and YUTIQ, an intravitreal implant containing fluocinolone acetonide, which targets chronic non-infectious uveitis impacting the posterior segment of the eye. The company also offers DEXYCU, a dexamethasone intraocular suspension, utilized to manage post-operative ocular inflammation, such as that occurring after cataract surgery. Looking ahead, EyePoint is actively developing several pipeline therapies. This includes EYP-1901, a novel, bioerodible tyrosine kinase inhibitor currently formulated for twice-yearly administration, which is under development for conditions like wet age-related macular degeneration, diabetic retinopathy, and retinal vein occlusion.
EYPT (EyePoint Pharmaceuticals, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $1.13B, a beta of 1.74 versus the broader market, a 52-week range of 9.65-19.11, average daily share volume of 1.2M, a public-listing history dating back to 2005, approximately 214 full-time employees. These structural characteristics shape how EYPT stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.74 indicates EYPT has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a butterfly on EYPT?
A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration.
EYPT snapshot
As of August 14, 2026, spot at $14.63, ATM IV 359.40%, IV rank 83.40%, expected move 103.04%. The butterfly on EYPT below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this butterfly structure on EYPT specifically: EYPT IV at 359.40% is rich versus its 1-year range, which makes a premium-buying EYPT butterfly relatively expensive in absolute-cost terms, with a market-implied 1-standard-deviation move of approximately 103.04% (roughly $15.07 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated EYPT expiries trade a higher absolute premium for lower per-day decay. Position sizing on EYPT should anchor to the underlying notional of $14.63 per share and to the trader's directional view on EYPT stock.
EYPT butterfly setup
The EYPT butterfly below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With EYPT at $14.63 on that close, the first option leg uses a $13.90 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed EYPT chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 EYPT shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $13.90 | N/A |
| Sell 2 | Call | $14.63 | N/A |
| Buy 1 | Call | $15.36 | N/A |
EYPT butterfly risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit.
EYPT butterfly payoff curve
Modeled P&L at expiration across a range of underlying prices for the butterfly on EYPT. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use butterfly on EYPT
Butterflies on EYPT are pinning bets - traders use them when they expect EYPT to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
EYPT thesis for this butterfly
The market-implied 1-standard-deviation range for EYPT extends from approximately $-0.44 on the downside to $29.70 on the upside. A EYPT long call butterfly is a pinning play: it pays maximum at the middle strike if EYPT settles there at expiration, with the wing legs capping both the cost and the maximum loss to the net debit. Current EYPT IV rank near 83.40% sits in the upper third of its 1-year distribution, which historically reverts; this raises the bar for premium-buying structures and lowers it for premium-selling structures on EYPT at 359.40%. As a Healthcare name, EYPT options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to EYPT-specific events.
EYPT butterfly positions are structurally neutral / pin (limited-risk, limited-reward); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. EYPT positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move EYPT alongside the broader basket even when EYPT-specific fundamentals are unchanged. Always rebuild the position from current EYPT chain quotes before placing a trade.
Frequently asked questions
- What is a butterfly on EYPT?
- A butterfly on EYPT is the butterfly strategy applied to EYPT (stock). The strategy is structurally neutral / pin (limited-risk, limited-reward): A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration. With EYPT stock at $14.63 on the most recent close, the strikes shown on this page are snapped to the nearest listed EYPT chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are EYPT butterfly max profit and max loss calculated?
- Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit. For the EYPT butterfly priced from the end-of-day chain at a 30-day expiry (ATM IV 359.40%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a EYPT butterfly?
- The breakeven for the EYPT butterfly priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The EYPT market-implied 1-standard-deviation expected move in the same options snapshot is approximately 103.04%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a butterfly on EYPT?
- Butterflies on EYPT are pinning bets - traders use them when they expect EYPT to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
- How does current EYPT implied volatility affect this butterfly?
- EYPT ATM IV is at 359.40% with IV rank near 83.40%, which is elevated relative to its 1-year range. Premium-selling structures (covered call, cash-secured put, iron condor) generally look more attractive when IV rank is high; premium-buying structures (long call, long put, debit spreads) are more expensive in that regime.